Quaker Wealth Management’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$65.9K Hold
408
– – 0.02% 144
2026
Q2
$77.4K Hold
408
– – 0.02% 133
2026
Q1
$80.5K Sell
408
-27
-6% -$5.21K 0.03% 123
2025
Q4
$80K Buy
435
+26
+6% +$4.56K 0.03% 130
2025
Q3
$62.7K Buy
409
+3
+0.7% +$454 0.02% 145
2025
Q2
$56.8K Buy
+406
New +$56.9K 0.02% 154

Other funds holding AZN

Quaker Wealth Management's AZN Position: Q3 2026 in Review

Quaker Wealth Management held its AstraZeneca (AZN) position steady in Q3 2026 at 408 shares worth $65.9K. The position accounts for 0.02% of the portfolio, ranked #144.

Quaker Wealth Management first reported a position in AZN in Q2 2025 and has held it in 6 quarters since. The position peaked at $80.5K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Quaker Wealth Management held 408 shares of AstraZeneca worth $65.9K as of Q3 2026.
  • Quaker Wealth Management left its AstraZeneca share count unchanged in Q3 2026.
  • AstraZeneca made up 0.02% of Quaker Wealth Management's portfolio in Q3 2026, its #144 holding.
  • Quaker Wealth Management first reported a position in AstraZeneca in Q2 2025 and has held it in 6 quarters since.
  • Quaker Wealth Management's AstraZeneca position peaked at $80.5K in Q1 2026.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.